Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 503 entries
Sorted by: Best Match Show Resources per page
Requirements engineering paper classification and evaluation criteria: a proposal and a discussion

evaluation

Wieringa R, Mead N, Rolland C.
GSID: XZkjQkoMh6EJ
R Wieringa, N Maiden, N Mead, C Rolland - Requirements engineering, 2006 - Springer

… Engineering (RE) Conference have discussed paper classification and evaluation criteria for RE papers. The immediate trigger for this … evaluation criteria in journals too. At one extreme is the set of nine genres used by IEEE Software [15],...

Cite
Wieringa, R., Maiden, N., Mead, N., & Rolland, C. (2006). Requirements engineering paper classification and evaluation criteria: a proposal and a discussion. Requirements engineering, 11(1), 102-107.
Wieringa, Roel, et al. "Requirements engineering paper classification and evaluation criteria: a proposal and a discussion." Requirements engineering 11.1 (2006): 102-107.
Copy Download .nbib Format: MLA
Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial

Pre-school

Read S.
GSID: NnCg8fnVXhQJ
S Awasthi, R Peto, S Read, S Clark, V Pande, D Bundy… - The Lancet, 2013 - Elsevier

… Participants in this cluster-randomised trial were pre-school children in the defined … Separately, all 8338 centres were visited every 6 months to monitor pre-school deaths (100 … of 6-monthly deworming with albendazole on pre-school child mortality were revised...

Cite
Awasthi, S., Peto, R., Read, S., Clark, S., Pande, V., Bundy, D., & DEVTA (Deworming and Enhanced Vitamin A) team. (2013). Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial. The Lancet, 381(9876), 1469-1477.
Awasthi, Shally, et al. "Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial." The Lancet 381.9876 (2013): 1469-1477.
Copy Download .nbib Format: MLA
Image of the scientist among high-school students: A pilot study

high school

Mead M.
GSID: 6PBF0gI3r6YJ
M Mead, R Metraux - Science, 1957 - science.org

… : sample A, a nation-wide sample of high schools, and sample B, a sample of high schools with widely different economic and educational … public high schools (including one junior high school) that were selected from schools associated...

Cite
Mead, M., & Metraux, R. (1957). Image of the scientist among high-school students: A pilot study. Science, 126(3270), 384-390.
Mead, Margaret, and Rhoda Metraux. "Image of the scientist among high-school students: A pilot study." Science 126.3270 (1957): 384-390.
Copy Download .nbib Format: MLA
Leveraging a Community of Practice to Build Faculty Resilience and Support Innovations in Teaching during a Time of Crisis

Cultural Transformation in the Geoscience Community AND Program Evaluation

Mead T.
GSID: 8JHSXTlYikQJ
T Mead, C Pietsch, V Matthew, S Lipkin-Moore… - Sustainability, 2021 - mdpi.com

Amidst the COVID-19 upheaval to higher education, a grantor-led community of practice (CoP) supported faculty members to deliver an innovative, sustainability-oriented entrepreneurship curriculum and maintain resiliency as teaching professionals. This paper discusses how through engagement in the CoP, this...

Cite
Mead, T., Pietsch, C., Matthew, V., Lipkin-Moore, S., Metzger, E., Avdeev, I. V., & Ruzycki, N. J. (2021). Leveraging a Community of Practice to Build Faculty Resilience and Support Innovations in Teaching during a Time of Crisis. Sustainability, 13(18), 10172.
Mead, Taryn, et al. "Leveraging a Community of Practice to Build Faculty Resilience and Support Innovations in Teaching during a Time of Crisis." Sustainability 13.18 (2021): 10172.
Copy Download .nbib Format: MLA
Aerosol Generation by Modern Flush Toilets.

Aerosol science and technology : the journal of the American Association for Aerosol Research

Johnson D, Lynch R, Marshall C, Mead K, Hirst D.
PMID: 26635429
Aerosol Sci Technol. 2013;47(9):1047-1057. doi: 10.1080/02786826.2013.814911.

A microbe-contaminated toilet will produce bioaerosols when flushed. We assessed toilet plume aerosol from high efficiency (HET), pressure-assisted high efficiency (PAT), and flushometer (FOM) toilets with similar bowl water and flush volumes. Total and droplet nuclei "bioaerosols" were assessed....

Cite
Johnson D, Lynch R, Marshall C, et al. Aerosol Generation by Modern Flush Toilets. Aerosol Sci Technol. 2013;47(9):1047-1057doi: 10.1080/02786826.2013.814911.
Johnson, D., Lynch, R., Marshall, C., Mead, K., & Hirst, D. (2013). Aerosol Generation by Modern Flush Toilets. Aerosol science and technology : the journal of the American Association for Aerosol Research, 47(9), 1047-1057. https://doi.org/10.1080/02786826.2013.814911
Johnson, David, et al. "Aerosol Generation by Modern Flush Toilets." Aerosol science and technology : the journal of the American Association for Aerosol Research vol. 47,9 (2013): 1047-1057. doi: https://doi.org/10.1080/02786826.2013.814911
Johnson D, Lynch R, Marshall C, Mead K, Hirst D. Aerosol Generation by Modern Flush Toilets. Aerosol Sci Technol. 2013;47(9):1047-1057. doi: 10.1080/02786826.2013.814911. PMID: 26635429; PMCID: PMC4666014.
Copy Download .nbib Format: NLM
Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease.

Clinical kidney journal

Vega A, Abad S, Macías N, Aragoncillo I, Santos A, Galán I, Cedeño S, Manuel López-Gómez J.
PMID: 28396734
Clin Kidney J. 2017 Apr;10(2):170-175. doi: 10.1093/ckj/sfw126. Epub 2017 Feb 08.

No abstract available.

Cite
Vega A, Abad S, Macías N, et al. Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clin Kidney J. 2017;10(2):170-175doi: 10.1093/ckj/sfw126.
Vega, A., Abad, S., Macías, N., Aragoncillo, I., Santos, A., Galán, I., Cedeño, S., & Manuel López-Gómez, J. (2017). Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clinical kidney journal, 10(2), 170-175. https://doi.org/10.1093/ckj/sfw126
Vega, Almudena, et al. "Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease." Clinical kidney journal vol. 10,2 (2017): 170-175. doi: https://doi.org/10.1093/ckj/sfw126
Vega A, Abad S, Macías N, Aragoncillo I, Santos A, Galán I, Cedeño S, Manuel López-Gómez J. Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clin Kidney J. 2017 Apr;10(2):170-175. doi: 10.1093/ckj/sfw126. Epub 2017 Feb 08. PMID: 28396734; PMCID: PMC5381238.
Copy Download .nbib Format: NLM
Bridging the Gap between Innovation and Financing. Chicago 2015 Health Venture Fair Awards.

World hospitals and health services : the official journal of the International Hospital Federation

Preker AS, Casillas J, Read S, Rogo K, Cleaton-Jones I, Funtleyder L.
PMID: 27180466
World Hosp Health Serv. 2016;52(1):7-9.

No abstract available.

Cite
Preker AS, Casillas J, Read S, et al. Bridging the Gap between Innovation and Financing. Chicago 2015 Health Venture Fair Awards. World Hosp Health Serv. 2016;52(1):7-9
Preker, A. S., Casillas, J., Read, S., Rogo, K., Cleaton-Jones, I., & Funtleyder, L. (2016). Bridging the Gap between Innovation and Financing. Chicago 2015 Health Venture Fair Awards. World hospitals and health services : the official journal of the International Hospital Federation, 52(1), 7-9.
Preker, Alexander S, et al. "Bridging the Gap between Innovation and Financing. Chicago 2015 Health Venture Fair Awards." World hospitals and health services : the official journal of the International Hospital Federation vol. 52,1 (2016): 7-9.
Preker AS, Casillas J, Read S, Rogo K, Cleaton-Jones I, Funtleyder L. Bridging the Gap between Innovation and Financing. Chicago 2015 Health Venture Fair Awards. World Hosp Health Serv. 2016;52(1):7-9. PMID: 27180466.
Copy Download .nbib Format: NLM
Quality standards for DNA sequence variation databases to improve clinical management under development in Australia.

Applied & translational genomics

Bennetts B, Caramins M, Hsu A, Lau C, Mead S, Meldrum C, Smith TD, Suthers G, Taylor GR, Cotton RG, Tyrrell V.
PMID: 27294016
Appl Transl Genom. 2014 Jul 10;3(3):54-7. doi: 10.1016/j.atg.2014.07.002. eCollection 2014 Sep 01.

Despite the routine nature of comparing sequence variations identified during clinical testing to database records, few databases meet quality requirements for clinical diagnostics. To address this issue, The Royal College of Pathologists of Australasia (RCPA) in collaboration with the...

Cite
Bennetts B, Caramins M, Hsu A, et al. Quality standards for DNA sequence variation databases to improve clinical management under development in Australia. Appl Transl Genom. 2014;3(3):54-7doi: 10.1016/j.atg.2014.07.002.
Bennetts, B., Caramins, M., Hsu, A., Lau, C., Mead, S., Meldrum, C., Smith, T. D., Suthers, G., Taylor, G. R., Cotton, R. G., & Tyrrell, V. (2014). Quality standards for DNA sequence variation databases to improve clinical management under development in Australia. Applied & translational genomics, 3(3), 54-7. https://doi.org/10.1016/j.atg.2014.07.002
Bennetts, B, et al. "Quality standards for DNA sequence variation databases to improve clinical management under development in Australia." Applied & translational genomics vol. 3,3 (2014): 54-7. doi: https://doi.org/10.1016/j.atg.2014.07.002
Bennetts B, Caramins M, Hsu A, Lau C, Mead S, Meldrum C, Smith TD, Suthers G, Taylor GR, Cotton RG, Tyrrell V. Quality standards for DNA sequence variation databases to improve clinical management under development in Australia. Appl Transl Genom. 2014 Jul 10;3(3):54-7. doi: 10.1016/j.atg.2014.07.002. eCollection 2014 Sep 01. PMID: 27294016; PMCID: PMC4888016.
Copy Download .nbib Format: NLM
Genetic Counseling: Clinical Geneticists' Views.

Journal of genetic counseling

Michie S, Smith JA, Heaversedge J, Read S.
PMID: 26142374
J Genet Couns. 1999 Oct;8(5):275-87. doi: 10.1023/A:1022930215375.

Evaluation of genetic counseling requires a clear consensus about its objectives, which is not evident in published definitions and guidelines. This study aims to investigate clinical geneticists' beliefs and thoughts about their practice. Structured interviews with eight clinical geneticists...

Cite
Michie S, Smith JA, Heaversedge J, et al. Genetic Counseling: Clinical Geneticists' Views. J Genet Couns. 1999;8(5):275-87doi: 10.1023/A:1022930215375.
Michie, S., Smith, J. A., Heaversedge, J., & Read, S. (1999). Genetic Counseling: Clinical Geneticists' Views. Journal of genetic counseling, 8(5), 275-87. https://doi.org/10.1023/A:1022930215375
Michie, S, et al. "Genetic Counseling: Clinical Geneticists' Views." Journal of genetic counseling vol. 8,5 (1999): 275-87. doi: https://doi.org/10.1023/A:1022930215375
Michie S, Smith JA, Heaversedge J, Read S. Genetic Counseling: Clinical Geneticists' Views. J Genet Couns. 1999 Oct;8(5):275-87. doi: 10.1023/A:1022930215375. PMID: 26142374.
Copy Download .nbib Format: NLM
Mesenchymal stem cell therapy for retinal ganglion cell neuroprotection and axon regeneration.

Neural regeneration research

Mead B, Scheven BA.
PMID: 25878580
Neural Regen Res. 2015 Mar;10(3):371-3. doi: 10.4103/1673-5374.153681.

No abstract available.

Cite
Mead B, Scheven BA. Mesenchymal stem cell therapy for retinal ganglion cell neuroprotection and axon regeneration. Neural Regen Res. 2015;10(3):371-3doi: 10.4103/1673-5374.153681.
Mead, B., & Scheven, B. A. (2015). Mesenchymal stem cell therapy for retinal ganglion cell neuroprotection and axon regeneration. Neural regeneration research, 10(3), 371-3. https://doi.org/10.4103/1673-5374.153681
Mead, Ben, and Scheven, Ben A. "Mesenchymal stem cell therapy for retinal ganglion cell neuroprotection and axon regeneration." Neural regeneration research vol. 10,3 (2015): 371-3. doi: https://doi.org/10.4103/1673-5374.153681
Mead B, Scheven BA. Mesenchymal stem cell therapy for retinal ganglion cell neuroprotection and axon regeneration. Neural Regen Res. 2015 Mar;10(3):371-3. doi: 10.4103/1673-5374.153681. PMID: 25878580; PMCID: PMC4396094.
Copy Download .nbib Format: NLM
The Biomechanics of Odorant Access to Aesthetascs in the Grass Shrimp, Palaemonetes vulgaris.

The Biological bulletin

Mead KS.
PMID: 28570189
Biol Bull. 1998 Oct;195(2):184-185. doi: 10.2307/1542828.

No abstract available.

Cite
Mead KS. The Biomechanics of Odorant Access to Aesthetascs in the Grass Shrimp, Palaemonetes vulgaris. Biol Bull. 1998;195(2):184-185doi: 10.2307/1542828.
Mead, K. S. (1998). The Biomechanics of Odorant Access to Aesthetascs in the Grass Shrimp, Palaemonetes vulgaris. The Biological bulletin, 195(2), 184-185. https://doi.org/10.2307/1542828
Mead, K S. "The Biomechanics of Odorant Access to Aesthetascs in the Grass Shrimp, Palaemonetes vulgaris." The Biological bulletin vol. 195,2 (1998): 184-185. doi: https://doi.org/10.2307/1542828
Mead KS. The Biomechanics of Odorant Access to Aesthetascs in the Grass Shrimp, Palaemonetes vulgaris. Biol Bull. 1998 Oct;195(2):184-185. doi: 10.2307/1542828. PMID: 28570189.
Copy Download .nbib Format: NLM
Integrated Process Modeling-A Process Validation Life Cycle Companion.

Bioengineering (Basel, Switzerland)

Zahel T, Hauer S, Mueller EM, Murphy P, Abad S, Vasilieva E, Maurer D, Brocard C, Reinisch D, Sagmeister P, Herwig C.
PMID: 29039771
Bioengineering (Basel). 2017 Oct 17;4(4). doi: 10.3390/bioengineering4040086.

During the regulatory requested process validation of pharmaceutical manufacturing processes, companies aim to identify, control, and continuously monitor process variation and its impact on critical quality attributes (CQAs) of the final product. It is difficult to directly connect the...

Cite
Zahel T, Hauer S, Mueller EM, et al. Integrated Process Modeling-A Process Validation Life Cycle Companion. Bioengineering (Basel). 2017;4(4)doi: 10.3390/bioengineering4040086.
Zahel, T., Hauer, S., Mueller, E. M., Murphy, P., Abad, S., Vasilieva, E., Maurer, D., Brocard, C., Reinisch, D., Sagmeister, P., & Herwig, C. (2017). Integrated Process Modeling-A Process Validation Life Cycle Companion. Bioengineering (Basel, Switzerland), 4(4), . https://doi.org/10.3390/bioengineering4040086
Zahel, Thomas, et al. "Integrated Process Modeling-A Process Validation Life Cycle Companion." Bioengineering (Basel, Switzerland) vol. 4,4 (2017). doi: https://doi.org/10.3390/bioengineering4040086
Zahel T, Hauer S, Mueller EM, Murphy P, Abad S, Vasilieva E, Maurer D, Brocard C, Reinisch D, Sagmeister P, Herwig C. Integrated Process Modeling-A Process Validation Life Cycle Companion. Bioengineering (Basel). 2017 Oct 17;4(4). doi: 10.3390/bioengineering4040086. PMID: 29039771; PMCID: PMC5746753.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 503 entries